Standex International Corp/de/
Market Movers (8-K)
NYSE
Standex International Corporation has acquired the remaining 9.9% stake in India-based Narayan Powertech for approximately $64 million, achieving full ownership.
NYSE
Standex International Corporation announced the promotion of Ademir Sarcevic to Executive Vice President, Corporate and Group President, Electronics, effective May 12, 2026.
NYSE
Standex International reported an 8.1% year-over-year sales increase to $224.6 million in Q3 2026, driven by strong performance in fast-growth markets and new product launches.
Better than expected
NYSE
Standex International Corporation announced robust second quarter fiscal year 2026 financial results, with sales increasing 16.6% year-over-year to $221.3 million and significant organic growth.
Delay expected
Better than expected
NYSE
Standex International Corporation announced the resignation of its Chief Human Resources Officer, Annemarie Bell, who will transition to a new role, and the appointment of Michelle Newbury as her successor.
NYSE
Standex International Corporation announced the results of its Annual Meeting, with stockholders electing two directors, approving executive compensation, and ratifying its independent public accountants.
Quarterly Earnings (10-Q)
NYSE
Standex International reports a 27.6% revenue increase driven by acquisitions, but net income and EPS decline due to higher interest and restructuring costs.
Delay expected
Worse than expected
Capital raise
NYSE
Standex International's Q3 2025 results show revenue growth driven by recent acquisitions, but organic sales were negatively impacted by softness in the automotive market.
Delay expected
Worse than expected
NYSE
Standex International's Q2 2025 results reveal a complex picture of growth driven by acquisitions offset by organic sales declines, impacting profitability.
Worse than expected
NYSE
10-Q: Standex International Reports Q1 2025 Results, Impacted by Sales Decline and Acquisition Costs
Standex International's first quarter results for fiscal year 2025 show a decrease in net sales and income from operations compared to the same period last year, influenced by lower organic sales and acquisition-related expenses.
Worse than expected
NYSE
Standex International Corporation's Q3 2024 results show a decrease in net sales and income from operations, influenced by strategic divestitures and acquisitions, alongside market headwinds.
Worse than expected
NYSE
Standex International's second quarter results for fiscal year 2024 show a decrease in net sales and income from operations compared to the prior year, influenced by market headwinds and strategic divestitures, but also highlighted by the acquisition of Minntronix.
Worse than expected
Annual Reports (10-K)
NYSE
Standex International Corporation filed an amendment to its annual report to include the SEC-mandated Compensation Clawback Policy, previously omitted.
NYSE
Standex International Corporation filed an amendment to its annual report to formally include its SEC-mandated Compensation Clawback Policy, adopted in August 2023.
NYSE
Standex International Corporation filed an amended 10-K solely to correct an inadvertent date error on the signature page, with no changes to financial results or disclosures.
NYSE
Standex International Corporation reported a 9.6% increase in net sales for fiscal year 2025 driven by strategic acquisitions, despite an organic sales decline and increased acquisition-related expenses.
Worse than expected
Delay expected
Capital raise
NYSE
Standex International Corporation's fiscal year 2024 saw a slight decrease in net sales and a significant drop in income from operations, influenced by market softness and strategic divestitures.
Worse than expected
Insider Trading (Form 4)
NYSE
Thomas E Chorman, a Director of Standex International Corp/De/, sold 50 shares of common stock on August 3, 2026 for $305.56 per share.
NYSE
Standex International Corp reports an award of Restricted Stock Units to Vice President/CFO/Treasurer Ademir Sarcevic.
NYSE
Thomas E. Chorman, a Director at Standex International Corp., reported a sale of 50 shares of common stock on July 1, 2026, executed under a pre-existing 10b5-1 trading plan.
NYSE
Director Barbara Joanne Edwards gifted 150 shares of Standex International Corp common stock to a charitable donor advised fund.
NYSE
Thomas E. Chorman, a Director at Standex International Corp., has sold 50 shares of common stock as part of a pre-arranged trading plan.
NYSE
Standex International Corporation Director Barbara Joanne Edwards sold 558 shares of common stock on May 27, 2026.
Proxy Statements (Def-14A)
NYSE
Standex International reports significant FY25 growth driven by strategic acquisitions and new products, alongside record safety performance and robust governance.
Better than expected
Delay expected
NYSE
Standex International Corporation files a supplement to its proxy statement to clarify the voting requirements and expected treatment of a by-law amendment under NYSE rules.
NYSE
Standex International Corporation is soliciting proxies for its 2024 Annual Meeting, featuring proposals to amend the Omnibus Incentive Plan and By-Laws, along with director elections and executive compensation advisory vote.
Worse than expected
Schedule 13G - Passive Investments
NYSE
Wasatch Advisors LP has reported a beneficial ownership of 7.0% in Standex International Corp., holding 846,255 shares.
NYSE
Neuberger Berman Group LLC and its affiliate Neuberger Berman Investment Advisers LLC have reported beneficial ownership of 4.7% of Standex International Corp.'s common stock as of May 31, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.23% of Standex International Corp.'s common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 751,868 shares, representing 6.2% of Standex International Corp.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Standex International Corp common stock following an internal realignment.
NYSE
Champlain Investment Partners, LLC reported a 4.0% beneficial ownership stake in Standex International Corp/DE/ common stock as of September 30, 2025.